All UK & Rest of Europe articles – Page 56
-
NewsPlant bacteria deploy phage elements to wipe out the competition
A new study has found that plant bacterial pathogens are able to repurpose elements of their own phages to wipe out competing microbes, suggesting such elements could someday be harnessed as an alternative to antibiotics.
-
NewsNew HIV reporter model: Visualizing HIV viral dynamics in cells with dual fluorescence
Researchers have developed a novel viral reporter system that allows for real-time visualization of HIV dynamics post-viral infection. HIV-Tocky features dual fluorescence to illuminate the process of provirus silencing and reactivation.
-
NewsMalta hosts groundbreaking 7th World Conference on Targeting Phage Therapy 2024
The historic Corinthia Palace in Malta is set to host the 7th World Conference on Targeting Phage Therapy on June 20-21, 2024. This event will bring together the world’s foremost leaders and researchers in bacteriophage therapy, highlighting the growing importance and global interest in this innovative field. ...
-
NewsScientists show the key role of spleen and extracellular vesicles in cryptic malaria infections
A new study has provided new insights into the role of the spleen in malaria, especifically in infections caused by the malaria parasite, Plasmodium vivax.
-
NewsNew study explores sun’s effects on the skin microbiome
A new study delves into existing knowledge on solar radiation’s impact on the skin microbiome and proposes innovative sun protection methods that safeguard both skin integrity and microbiome balance.
-
NewsStudy reveals role of fathers in seeding the microbiota of newborns
A new paper shows the important contributions that fathers make to the composition of microbes colonizing a baby’s gut, and confirms that maternal fecal microbiota transfer (FMT) in babies born by C-section can help to correct microbiota disturbances.
-
NewsInnovative phage lysin HY-133 enters phase I clinical study
HYpharm’s innovative preventive agent HY-133 has reached the first clinical trial phase. HY-133 is specifically effective against Staphylococcus aureus including multi-resistant strains and is intended to combat its colonisation in the nose.
-
NewsTwo types of polymicrobial infections in chronic lung diseases
Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment. The study was published in the journal ...
-
NewsTwo ways that members of the microbiome fight salmonella infections
Researchers have identified two mechanisms through which Klebsiella bacteria combat the spread of salmonella in the gut.
-
NewsNew discovery reveals unexpected ocean algae help cool the Earth
A common type of ocean algae plays a significant role in producing a massively abundant compound that helps cool the Earth’s climate, new research has discovered.
-
NewsNew 3D printed imaging device combines education and microbial research
Researchers have developed a 3D-printed imaging device for schools and research centres to study microbes. It enables schools to observe natural phenomena, while researchers will gain useful knowledge about the light-activated bacteria.
-
NewsHepatitis E virus scoops up human derived RNA fragments
In cell culture experiments, it was shown that incorporating host RNA provided a replication advantage for the Hepatitis E virus, with the altered viruses replicating better than others.
-
CareersScientists put Mars DNA sampling protocols to the test with help from AMI grant
Thanks to support from Applied MIcrobiology International, scientists testing sampling collection protocols in Mars analogue conditions have shown that non-scientists will be able to replicate the tests as long as they follow the methods.
-
NewsLung organoids unveil secret of how pathogens infect human lung tissue
Using human lung microtissues, researchers have uncovered the strategy used by a dangerous pathogen to invade the lungs. Pseudomonas aeruginosa targets specific lung cells and has developed a sophisticated strategy to break through the lungs’ line of defense.
-
NewsNovel lipopeptide produced by bacterium proves lethal against Staphylococcus aureus
A novel antibacterial lipopeptide produced by the bacterium Serratia marcescens has been shown to be highly effective in killing Staphylococcus aureus – one of the most important pathogens occurring in humans.
-
NewsNew study reveals that marine cyanobacteria can communicate using membrane nanotubes
Transfer of substances via membrane nanotubes not only occurs in cyanobacteria of the same lineage, but also between those of different genders, something that has been verified not only at the laboratory level, but also in natural ocean samples.
-
NewsItaly pertussis outbreak hospitalises 108 and claims 3 lives
A significant pertussis outbreak, predominantly affecting neonates and young infants, saw 108 hospitalisations and three deaths. Its resurgence may be attributed to limited maternal immunisation during pregnancy and increased circulation post-COVID-19 pandemic.
-
NewsLiposomes can target antibiotics right to where they’re needed in wounds
The antibiotic gentamicin can be encapsulated into liposomes, allowing for more accurate use in situations such as wound treatment, according to new research presented at the recent Letters in Applied Microbiology ECS Research Symposium.
-
NewsEpstein-Barr Virus and brain cross-reactivity: possible mechanism for multiple sclerosis unveiled
The role that Epstein-Barr Virus (EBV) plays in the development of multiple sclerosis (MS) may be caused by a higher level of cross-reactivity, where the body’s immune system binds to the wrong target, than previously thought.
-
NewsStudy finds antimicrobial resistance in soils across Scotland
Resistance to antibiotics has been found in the environment across Scotland, according to a new study.